Australia Últimas notícias

Biome (ASX:BIO) has delivered its performance for the first half of FY26, headlined by a net profit of $1.2 million, a 172% increase over the previous year.

EVT (ASX:EVT) logged normalised revenue rose 5.4% to $683.8 million for H1, while normalised profit after tax rose 28.5% to $40.5 million.

Sean Stein, President at the US-China Business Council, discusses the uncertainty around the US trade tariffs and the impact for businesses navigating in China. He speaks with Avril Hong and Shery Ahn on Bloomberg: The Asia Trade.

Minerals 260 (ASX:MI6) announced a $220 million strategic funding agreement with Franco-Nevada Corporation to accelerate the development of its Bullabulling Gold Project.

Kogan.com (ASX:KGN) released its financial results for the first half of fiscal year 2026, revealing a total gross sales of $572.4 million, representing a 16% year-on-year increase.

Deborah Elms, Head of Trade Policy at the Hinrich Foundation, discusses the latest developments with President Trump's trade tariffs after the US Supreme Court struck down many of the levies he imposed last year. She speaks with Avril Hong and Shery Ahn on Bloomberg: The Asia Trade.

IMDEX (ASX:IMD) reported its strongest first-half performance on record for the period ended Dec. 31, 2025, driven by market share gains and increased technology adoption.

OFX Group (ASX:OFX) appointed James Georgeson as its new CFO, effective Feb. 23.

Adairs (ASX:ADH) achieved record total sales of $329 million in H1 FY26, marking a 5.9% increase compared to the same period last year.

Celsius Resources (ASX:CLA) has secured firm commitments to raise $9.3 million through an institutionally backed placement.

Aged care giant Regis Healthcare (ASX:REG) reported a sharp 45.1% decline in statutory net profit for the first half of FY26, falling to $13.4 million.

Mayne Pharma (ASX:MYX) reported revenue of $212.1 million for the first half of FY26, a marginal 0.5% decrease compared to the previous corresponding period.